Patents by Inventor Yuri McKee

Yuri McKee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Ocular drug delivery devices
    Patent number: 11730697
    Abstract: A method of forming an ocular delivery device includes exposing a solid, shaped cellulose polymer to a solution including an active pharmaceutical ingredient (API) and a solvent capable of solubilizing the API, wherein the polymer absorbs at least a portion of the solution, including the API and solvent. The method may further include removing at least a portion of the absorbed solvent from the polymer by allowing the absorbed solvent to evaporate from the polymer or by drying the polymer. A variety of cellulose polymers may be used, including hydroxypropyl cellulose. A variety of APIs may be used, including Cyclosporine, Tobramycin and Vancomycin. Ocular delivery devices prepared by the methods may be used to treat a variety of eye disorders.
    Type: Grant
    Filed: January 7, 2019
    Date of Patent: August 22, 2023
    Assignees: Bausch Health Americas, Inc., Louisiana State University Agricultural and Mechanical College
    Inventors: Jean Theresa Jacob, Kevin John Halloran, Yuri McKee
  • Ocular Drug Delivery Devices
    Publication number: 20190133934
    Abstract: A method of forming an ocular delivery device includes exposing a solid, shaped cellulose polymer to a solution including an active pharmaceutical ingredient (API) and a solvent capable of solubilizing the API, wherein the polymer absorbs at least a portion of the solution, including the API and solvent. The method may further include removing at least a portion of the absorbed solvent from the polymer by allowing the absorbed solvent to evaporate from the polymer or by drying the polymer. A variety of cellulose polymers may be used, including hydroxypropyl cellulose. A variety of APIs may be used, including Cyclosporine, Tobramycin and Vancomycin. Ocular delivery devices prepared by the methods may be used to treat a variety of eye disorders.
    Type: Application
    Filed: January 7, 2019
    Publication date: May 9, 2019
    Applicants: Aton Pharma, Inc., Louisiana State University Agricultural and Mechanical College
    Inventors: Jean Theresa JACOB, Kevin John HALLORAN, Yuri MCKEE
  • Ocular Drug Delivery Devices
    Publication number: 20140187497
    Abstract: A method of forming an ocular delivery device includes exposing a solid, shaped cellulose polymer to a solution including an active pharmaceutical ingredient (API) and a solvent capable of solubilizing the API, wherein the polymer absorbs at least a portion of the solution, including the API and solvent. The method may further include removing at least a portion of the absorbed solvent from the polymer by allowing the absorbed solvent to evaporate from the polymer or by drying the polymer. A variety of cellulose polymers may be used, including hydroxypropyl cellulose. A variety of APIs may be used, including Cyclosporine, Tobramycin and Vancomycin. Ocular delivery devices prepared by the methods may be used to treat a variety of eye disorders.
    Type: Application
    Filed: November 22, 2013
    Publication date: July 3, 2014
    Applicants: Louisiana State University Agricultural and Mechanical College, ATON PHARMA, INC.
    Inventors: Jean Theresa JACOB, Kevin John HALLORAN, Yuri MCKEE
  • OCULAR DRUG DELIVERY DEVICES
    Publication number: 20110129516
    Abstract: A method of forming an ocular delivery device includes exposing a solid, shaped cellulose polymer to a solution including an active pharmaceutical ingredient (API) and a solvent capable of solubilizing the API, wherein the polymer absorbs at least a portion of the solution, including the API and solvent. The method may further include removing at least a portion of the absorbed solvent from the polymer by allowing the absorbed solvent to evaporate from the polymer or by drying the polymer. A variety of cellulose polymers may be used, including hydroxypropyl cellulose. A variety of APIs may be used, including Cyclosporine, Tobramycin and Vancomycin. Ocular delivery devices prepared by the methods may be used to treat a variety of eye disorders.
    Type: Application
    Filed: October 29, 2010
    Publication date: June 2, 2011
    Inventors: Jean Theresa JACOB, Kevin John Halloran, Yuri McKee